Repligen Corporation (RGEN) Cash Flow Statement
Repligen Corporation (RGEN) generated $134.9M of operating cash flow over the twelve months to 2026-06-30, spent $24.7M on capital expenditure and had free cash flow of $110.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RGENRepligen CorporationFollow RGEN — free
—
Price chart with a free account
- Market cap
- 10.0B
- P/E TTM
- 242.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
| Line | FY2011 Mar 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.00 | 0.01 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.07 | 0.06 | 0.12 | 0.17 | 0.11 | 0.18 | 0.12 | 0.13 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.07 | 0.09 | 0.04 | 0.03 | 0.03 | -0.02 | |
| Free cash flow | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 | 0.05 | 0.08 | 0.07 | 0.15 | 0.09 | 0.11 | |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | 0.01 | 0.00 | 0.00 | — | |
| Stock-based compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.05 | 0.03 | — |
USD billions · SEC XBRL
Repligen Corporation — questions
- What is Repligen Corporation's operating cash flow?
- $134.9M over the twelve months to 2026-06-30.
- How much does Repligen Corporation spend on capital expenditure?
- $24.7M over the twelve months to 2026-06-30.
- What is Repligen Corporation's free cash flow?
- $110.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Repligen Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.